Literature DB >> 12517415

In vitro characterization of a human calcitonin receptor gene polymorphism.

Lawrence A Wolfe1, Mary E Fling, Zhengyu Xue, Susan Armour, Sandra A Kerner, James Way, Tom Rimele, Richard F Cox.   

Abstract

Calcitonin is a 32 amino acid peptide hormone that inhibits bone resorption by stimulating calcitonin receptors (CTR) located on the surfaces of osteoclasts. A polymorphism at nucleotide 1340 of the human calcitonin receptor gene (CALCR) lies within the coding region and has the potential to change the amino acid at codon 447 from leucine to proline. In the present study, we scanned the coding region, portions of the 5'-flanking and 3'-flanking sequences, and the intron-exon boundaries of the human CALCR gene for additional polymorphisms, and determined the frequency of the codon 447 polymorphism in several ethnic groups. Because a leucine to proline change has the potential for significant structural alteration, receptor genes encoding either leucine or proline at residue 447 were transiently expressed in COS-7 cells to determine the binding and functional consequences of this polymorphism. Our complete polymorphism scan of the CALCR gene identified 11 polymorphic sites in the gene and confirmed the presence of the previously identified nucleotide T1340C (codon 447) polymorphism. Ten of the 11 polymorphisms were single nucleotide polymorphisms (SNPs). For the codon 447 polymorphism, the prevalence of the TT genotype (leucine) was 59% in Caucasians, 27% in African-Americans, 0% in Asians, and 20% in Hispanics. The presence of this SNP appears to have no statistically significant difference with the receptor's ability to bind calcitonin or signal when activated with the hormone. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517415     DOI: 10.1016/s0027-5107(02)00282-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  [Association between root abnormalities and related pathogenic genes in patients with generalized aggressive periodontitis].

Authors:  J Liu; X E Wang; D Lv; M Qiao; L Zhang; H X Meng; L Xu; M X Mao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-09

2.  Calcitonin and calcitonin receptors.

Authors:  Laura Masi; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

3.  Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions.

Authors:  Fahmy T Ali; Eman M Abd El-Azeem; Hala F A Hekal; Mayada M El-Gizawy; Mohamed S Sayed; AbdAllah Y Mandoh; Ahmed F Soliman
Journal:  Urolithiasis       Date:  2022-09-11       Impact factor: 2.861

4.  Calcitonin receptor gene polymorphism in cCinese Xinjiang Han and Uygur women with primary osteoporosis.

Authors:  J Xu; Y Gao; J Yin; X Zhao; H Wang; H Yuan; F Wang
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

5.  Fracture, bone mineral density, and the effects of calcitonin receptor gene in postmenopausal Koreans.

Authors:  H-J Lee; S-Y Kim; G S Kim; J-Y Hwang; Y-J Kim; B Jeong; T-H Kim; E K Park; S H Lee; H-L Kim; J-M Koh; J-Y Lee
Journal:  Osteoporos Int       Date:  2009-11-28       Impact factor: 4.507

6.  Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas.

Authors:  Maria Musumeci; Gianluca Vadalà; Giovanni Tringali; Elio Insirello; Anna Maria Roccazzello; Jacques Simpore; Salvatore Musumeci
Journal:  J Bone Miner Metab       Date:  2009-03-03       Impact factor: 2.626

7.  Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.

Authors:  J M Zmuda; L M Yerges-Armstrong; S P Moffett; L Klei; C M Kammerer; K Roeder; J A Cauley; A Kuipers; K E Ensrud; C S Nestlerode; A R Hoffman; C E Lewis; T F Lang; E Barrett-Connor; R E Ferrell; E S Orwoll
Journal:  Osteoporos Int       Date:  2010-12-09       Impact factor: 4.507

8.  Identification of the calcitonin receptor in osteoarthritic chondrocytes.

Authors:  Toni Segovia-Silvestre; Caroline Bonnefond; Bodil C Sondergaard; Tjorbjoern Christensen; Morten A Karsdal; Anne C Bay-Jensen
Journal:  BMC Res Notes       Date:  2011-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.